Related Experiment Video
Updated: Jun 18, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Correlation of Visual System Biomarkers With Motor Deficits in Experimental Autoimmune Encephalomyelitis-Optic
Benjamin W Elwood1,2, Cheyanne R Godwin1,2, Jeffrey J Anders1,2,3
1Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA.
Visual biomarkers like pattern electroretinography and OCT offer objective outcomes for multiple sclerosis (MS) research. These methods directly assess optic nerve damage in experimental autoimmune encephalomyelitis (EAE) models, improving therapeutic testing.
Area of Science:
- Neuroscience
- Ophthalmology
- Immunology
Background:
- Experimental autoimmune encephalomyelitis (EAE) is a key animal model for multiple sclerosis (MS).
- Current EAE scoring methods are subjective and variable, hindering research progress.
- There is a need for objective, clinically relevant outcome measures in EAE studies.
Purpose of the Study:
- To explore visual biomarkers as objective primary outcomes in the EAE model.
- To assess the correlation between visual function/structure and motor impairment in EAE.
- To establish clinically relevant outcome measures for MS research.
Main Methods:
- Mice with EAE were scored for motor impairment.
- Pattern electroretinography (pERG) and optical coherence tomography (OCT) measured retinal function and structure.
- Optic nerve histopathology analyzed demyelination and immune cell infiltration.
Main Results:
- pERG amplitude and RGC/IPL thickness correlated significantly with EAE scores.
- OCT detected RGC/IPL thinning correlating with EAE severity and pERG amplitude.
- Histopathology confirmed correlations between optic nerve damage and visual biomarker measurements.
Conclusions:
- pERG and OCT provide objective, direct assessments of optic nerve involvement in EAE.
- Visual biomarkers reflect both optic nerve pathology and motor deficits in this MS model.
- These visual outcomes can serve as robust primary endpoints for MS therapeutic development.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
08:05Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017